The American Hospital Association is once again raising concerns about how a major drugmaker handles the government’s 340B ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and financial resilience in 2026.

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the 340B Drug Pricing Program. The complaint claims Amgen bypassed federal ...

HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

A federal judge granted a temporary restraining order to block a pilot program aimed at keeping better tabs on the federal340B program.

The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.

The 340B Drug Pricing Program (340B Program) is no stranger to controversy. We have previously covered the ongoing contract pharmacy legal battles and the new alternative dispute resolution process.

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...

What does it mean to be a patient? For some, it means access to the best doctors and hospitals. For others, it means a courageous battle against a chronic, and perhaps incurable disease. And for many, ...

Continued support of 340B is vital for diverse communities and small business owners in the state.